PCMD Initiates Clinical Trial On COVID-19 Patients By TCM
Umer Jamshaid Published September 28, 2020 | 05:48 PM
Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi has initiated the clinical trial of the Traditional Chinese Medicine (TCM) "Jinhua Qinggan Granules" in Pakistan for the treatment of COVID-19 mild patients
KARACHI, (UrduPoint / Pakistan Point News - 28th Sep, 2020 ) :Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi has initiated the clinical trial of the Traditional Chinese Medicine (TCM) "Jinhua Qinggan Granules" in Pakistan for the treatment of COVID-19 mild patients.
Director of the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, and COMSTECH Coordinator-General Prof. Dr. M. Iqbal Choudhary expressed these views while speaking at a meeting held at the CBSCR, said a statement here on Monday.
The Center for Bioequivalence Studies and Clinical Research (CBSCR), which works as a component of Dr. Panjwani Center, in collaboration with the Indus Hospital, initiated the a clinical trial of the Jinhua Qinggan Granules in Pakistan as a revolutionary step in the country's health care system.
Incharge of CBSCR and principal investigator of the study Prof. Dr. Raza Shah was also present on the occasion.
Prof. Choudhary congratulated the team of scientists working at the CBCSR on this important development, and pointed out that the initiation of a clinical trial of traditional Chinese medicine in Pakistan was a revolutionary step in the country's health care system, adding that the herb-based Chinese medicine would be the treatment of COVID-19 mild patients.
The effectiveness and safety of the Jinhua Qinggan Granules will be evaluated on 300 mild-category patients of COVID-19 in the Pakistani population-both male and female, within 5th to 10th days, he said.
The study is carried out after the approval of the National Bioethics Committee and Drug Regulatory Authority of Pakistan, he mentioned.
The CBSCR of Dr. Panjwani Center has also received a license from DRAP to act as a contract research organization (CRO) to conduct clinical trials for national and the international market, Prof. Choudhary said, adding that the center had already conducted clinical trials for Chinese and western pharmaceutical companies.
This was the only clinical trial facility well known for high quality and excellence in clinical research, he said.
Prof. Dr. Raza Shah said, "This traditional medicine is the combination of natural herbs and widely used during the pandemic of COVID-19 in China."Its efficacy and safety were evaluated by pharmacodynamics, toxicology, phase II and III clinical studies and used as the approved OTC drug for the treatment of COVID-19 patients, he said, adding that now Jinhua Qinggan Granules had been widely used in clinical practices in China, and its curative effect was significant.
It is pertinent to mention here that the Vice-Chancellor University of Karachi Prof. Dr. Khalid Mehmood Irqai, ICCBS Patron-in-chief and Chairman of Prime Minister's Task Force on Science and Technology, Prof. Atta-ur Rahman, Chairperson Dr. Panjwani Memorial Trust Ms. Nadira Panjwani, and Chairman H.E.J. Foundation Aziz Latif Jamal congratulated Prof. Iqbal Choudhary and his team in recognition of their efforts.
Related Topics
Recent Stories
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
More Stories From Pakistan
-
Naval Chief participates in 19th Western Pacific Naval Symposium in China
7 hours ago -
Int'l symposium addresses capacity building for safe, environmentally sound ship recycling in Pakist ..
8 hours ago -
Shahzeb Chachar to hold khuli kachehri on April 26
8 hours ago -
Court adjourns Judicial Complex attack case till May 17
8 hours ago -
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
8 hours ago -
Wafaqi Mohtasib inspection team visits Excise and taxation office
8 hours ago
-
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil Rights in South Asia ..
9 hours ago -
IBCC to promote educational excellence, expand regional presence
9 hours ago -
Pakistan embassy organizes scholarship award ceremony in Kathmandu
9 hours ago -
SC to hear case pertaining IHC judges' letter on April 30
9 hours ago -
SC orders removal of barriers outside buildings in Karachi
9 hours ago -
PFA launches crackdown, impose fine for selling expired drinks, food items
9 hours ago